A Phase II trial of AR1001 for Vascular dementia.
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2016
At a glance
- Drugs AR 1001 (Primary)
- Indications Vascular dementia
- Focus Therapeutic Use
- 20 Oct 2016 New trial record
- 01 Jun 2016 According to an AriBio media release, this trial will be lodged to FDA by 2017.